6.48
price down icon1.67%   -0.11
after-market After Hours: 6.29 -0.19 -2.93%
loading
Aclarion Inc stock is traded at $6.48, with a volume of 7,290. It is down -1.67% in the last 24 hours and down -3.28% over the past month. Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$6.59
Open:
$6.63
24h Volume:
7,290
Relative Volume:
0.04
Market Cap:
$3.76M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.7129
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
-3.28%
1M Performance:
-3.28%
6M Performance:
+33.33%
1Y Performance:
-22.83%
1-Day Range:
Value
$6.2901
$6.63
1-Week Range:
Value
$6.2901
$7.00
52-Week Range:
Value
$0.7425
$562.68

Aclarion Inc Stock (ACON) Company Profile

Name
Name
Aclarion Inc
Name
Phone
833 275 2266
Name
Address
8181 ARISTA PLACE, BROOMFIELD
Name
Employee
6
Name
Twitter
Name
Next Earnings Date
Name
Latest SEC Filings
Name
ACON's Discussions on Twitter

Compare ACON with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Health Information Services icon
ACON
Aclarion Inc
6.48 3.90M 49,300 -6.27M -5.38M -9.09
Health Information Services icon
VEEV
Veeva Systems Inc
279.70 37.97B 2.86B 780.66M 1.20B 4.72
Health Information Services icon
TEM
Tempus Ai Inc
55.18 10.83B 803.32M -709.10M -212.68M -7.8003
Health Information Services icon
HQY
Healthequity Inc
100.61 8.58B 1.15B 96.70M -161.99M 1.09
Health Information Services icon
DOCS
Doximity Inc
52.09 9.58B 550.17M 201.35M 232.07M 1.00
Health Information Services icon
WAY
Waystar Holding Corp
39.98 6.68B 906.14M -52.62M 89.62M -0.3621

Aclarion Inc Stock (ACON) Latest News

pulisher
May 31, 2025

Aclarion (NASDAQ:ACON) Upgraded by Wall Street Zen to Hold Rating - Defense World

May 31, 2025
pulisher
May 30, 2025

Aclarion stock price target cut to $20 at Ascendiant Capital By Investing.com - Investing.com India

May 30, 2025
pulisher
May 30, 2025

Aclarion stock price target cut to $20 at Ascendiant Capital - Investing.com

May 30, 2025
pulisher
May 29, 2025

Aclarion, Inc. (NASDAQ:ACON) Sees Large Drop in Short Interest - Defense World

May 29, 2025
pulisher
May 22, 2025

Aclarion (NASDAQ:ACON) Trading Down 1.2% – Here’s Why - Defense World

May 22, 2025
pulisher
May 20, 2025

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site - Ortho Spine News

May 20, 2025
pulisher
May 20, 2025

USC Medical Center Joins Groundbreaking AI Trial to Revolutionize Chronic Back Pain Diagnosis - Stock Titan

May 20, 2025
pulisher
May 15, 2025

Aclarion, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 13, 2025

Aclarion (ACON) Expands CLARITY Trial with Texas Back Institute - GuruFocus

May 13, 2025
pulisher
May 12, 2025

Aclarion Announces Texas Back Institute as New CLARITY Trial Site - Ortho Spine News

May 12, 2025
pulisher
May 12, 2025

Aclarion announces Texas Back Insitute as new CLARITY trial site - TipRanks

May 12, 2025
pulisher
May 12, 2025

Aclarion Inc. Partners with Texas Back Institute for CLARITY Clinical Trial to Enhance Chronic Low Back Pain Treatment - Nasdaq

May 12, 2025
pulisher
May 12, 2025

History Says Now Is the Time to Buy Nvidia Stock - The Globe and Mail

May 12, 2025
pulisher
May 12, 2025

Aclarion (ACON) Expands CLARITY Trial with Texas Back Institute | ACON Stock News - GuruFocus

May 12, 2025
pulisher
May 05, 2025

Aclarion Welcomes Advocate Health as CLARITY Trial Site - Ortho Spine News

May 05, 2025
pulisher
May 05, 2025

Major Breakthrough: Advocate Health to Test AI-Powered Spine Pain Diagnostic in 300-Patient Trial - Stock Titan

May 05, 2025
pulisher
May 03, 2025

Aclarion secures funding for pivotal CLARITY trial - MSN

May 03, 2025
pulisher
Apr 29, 2025

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - Ortho Spine News

Apr 29, 2025
pulisher
Apr 29, 2025

Aclarion (ACON) Partners with Louisiana Spine Institute to Expan - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Aclarion announces agreement with the Spine Institute of Louisiana - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

Aclarion Expands Nociscan Access with Commercial Agreement at Spine Institute of Louisiana - Nasdaq

Apr 29, 2025
pulisher
Apr 29, 2025

Revolutionary Spine Pain Technology Nociscan Achieves 97% Success Rate, Expands to 17 Medical Centers - Stock Titan

Apr 29, 2025
pulisher
Apr 28, 2025

Aclarion stock hits 52-week low at $7.25 amid steep annual decline By Investing.com - Investing.com South Africa

Apr 28, 2025
pulisher
Apr 28, 2025

Aclarion stock hits 52-week low at $7.25 amid steep annual decline - Investing.com

Apr 28, 2025
pulisher
Apr 27, 2025

Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Aclarion Inc Files For Mixed Shelf Of Up To $150 MlnSEC Filing - marketscreener.com

Apr 25, 2025
pulisher
Apr 23, 2025

Aclarion Releases Updated Investor Presentation at Showcase - TipRanks

Apr 23, 2025
pulisher
Apr 23, 2025

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - The Manila Times

Apr 23, 2025
pulisher
Apr 23, 2025

Aclarion, Inc. to Present at Planet MicroCap Showcase: VEGAS 2025 on Chronic Low Back Pain Solutions - Nasdaq

Apr 23, 2025
pulisher
Apr 23, 2025

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet ... - Bluefield Daily Telegraph

Apr 23, 2025
pulisher
Apr 23, 2025

Aclarion's Revolutionary AI Approach to Chronic Back Pain: New Investor Strategy Revealed at MicroCap Vegas - Stock Titan

Apr 23, 2025
pulisher
Apr 22, 2025

3 Reasons to Buy Amazon Stock Like There's No Tomorrow - The Globe and Mail

Apr 22, 2025
pulisher
Apr 21, 2025

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis - Ortho Spine News

Apr 21, 2025
pulisher
Apr 21, 2025

Aclarion's Nociscan Demonstrates Cost-Effectiveness and Improved Surgical Success Compared to Provocative Discography - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

New Research: AI-Powered Spine Technology Cuts Patient Costs by $1,712, Boosts Surgery Success 10% - Stock Titan

Apr 21, 2025
pulisher
Apr 12, 2025

NOCISCAN touted as lumbar pain diagnostic advance - MSN

Apr 12, 2025
pulisher
Apr 11, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 11, 2025
pulisher
Apr 09, 2025

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub - The Manila Times

Apr 09, 2025
pulisher
Apr 09, 2025

Aclarion, Inc. SEC 10-K Report - TradingView

Apr 09, 2025
pulisher
Apr 08, 2025

Aclarion stock hits 52-week low at $9.68 amid steep annual decline - Investing.com Canada

Apr 08, 2025
pulisher
Apr 07, 2025

Aclarion stock hits 52-week low at $9.68 amid steep annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025
pulisher
Apr 02, 2025

Aclarion ‘s Nociscan now available in Santa Monica at MICSC - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Aclarion Announces Expansion to Santa Monica with Medical Imaging Center of Southern California - The Manila Times

Apr 02, 2025
pulisher
Apr 02, 2025

Revolutionary AI-Powered Back Pain Diagnostic Tool Gains Ground in Los Angeles Healthcare Market - Stock Titan

Apr 02, 2025
pulisher
Apr 01, 2025

EXCLUSIVE: March's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Nvidia, Apple, Applovin Stock Rank?Apple (NASDAQ:AAPL), Aclarion (NASDAQ:ACON) - Benzinga

Apr 01, 2025
pulisher
Mar 31, 2025

Aclarion, Inc. Delays Annual Report Filing - TipRanks

Mar 31, 2025
pulisher
Mar 31, 2025

Aclarion Provides Update on Strength of Company Positioning Following Q1 Strategic Initiatives - Ortho Spine News

Mar 31, 2025
pulisher
Mar 31, 2025

Aclarion provides corporate update following Q1 strategic initiatives - TipRanks

Mar 31, 2025

Aclarion Inc Stock (ACON) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
health_information_services PHR
$24.49
price up icon 0.25%
$11.36
price down icon 0.35%
$22.98
price up icon 0.04%
$22.76
price up icon 0.93%
$23.81
price up icon 1.75%
health_information_services WAY
$39.98
price up icon 3.68%
Cap:     |  Volume (24h):